Quantcast

Latest Cholangiocarcinoma Stories

2009-06-01 07:46:36

Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease. Researchers have developed new tests that double the ability to detect bile duct and pancreatic cancers, according to a Mayo Clinic study published in the June issue of Gastroenterology.Pancreatobiliary tumors such as bile duct cancer (cholangiocarcinoma) and pancreatic cancer often present as strictures, or a narrowing of the duct that can either...

2009-05-28 07:30:00

Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that 14 abstracts and additional clinical data analyses involving the SpyGlass(R) Direct Visualization System will be presented at Digestive Disease Week(R) (DDW), which runs from May 30 to June 4 in Chicago. "The impressive number of...

2009-05-06 07:00:00

- Survey of AOSW Members Highlights Need for Resources, Education, Better Diagnostic Tools to Reduce Psychological Impact of Unknown Cancer Diagnoses - SAVANNAH, Ga., May 6 /PRNewswire/ -- Cancer patients whose primary cancer type is "uncertain" or "unknown" may experience more distress than patients whose primary cancer is definitively diagnosed, according to a recent survey of 140 oncology social workers. bioTheranostics, a company specializing in molecular diagnostics for oncology,...

2009-04-07 06:30:00

CALGARY, April 7 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced positive results in its U.K. Phase II clinical trial to evaluate the objective tumour response rate of REOLYSIN(R) in combination with low-dose radiation in patients with advanced cancers. A total of 16 heavily pretreated patients with advanced cancer (melanoma (5), colorectal (4), gastric (1), pancreas (1), ovarian (1), lung (1), cholangiocarcinoma (1), sinus (1), and...

2009-03-19 08:40:00

WOONSOCKET, R.I., March 19 /PRNewswire-FirstCall/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has entered into a cooperative research and development agreement with Maxim Biotech, Inc. to develop products for the study of liver stem cells and liver cancer. Tumor tissues are composed of a mixture of cells with some tumor cells exhibiting stem cell-like properties (cancer stem cells). Cancer stem cells are thought to play a role in a tumor's resistance to...

2009-01-19 07:00:00

HOLLYWOOD, Fla., Jan. 19 /PRNewswire/ -- Using tiny chemotherapy-soaked beads to choke off and kill cancerous liver tumors is becoming more successful, according to research being presented at the 21st annual International Symposium on Endovascular Therapy (ISET). Transarterial chemoembolization (TACE) is a minimally invasive therapy that takes a two-pronged approach to treating cancer. Interventional physicians use minimally invasive methods to deliver the beads (also called microspheres)...

2008-11-25 20:09:31

Administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumors, U.S. researchers found. Senior author Dr. David Sherr of Weill Cornell Medical College and New York-Presbyterian Hospital/Weill Cornell Medical Center said that because pancreatic tumors have often spread or have directly invaded critical structures by the time they are detected, just 15 percent to 20 percent of patients are deemed suitable candidates for surgical...

2008-09-04 09:00:08

By Lois M. Collins Deseret News Surgeons and oncologists at the University of Utah are using liver transplants to treat a rare, deadly cancer. Cholangiocarcinoma -- bile duct cancer -- previously had no effective therapy and is usually lethal. "Once it's diagnosed, the prognosis is very grim," said Dr. Jason Schwartz, assistant professor of transplant surgery and a surgeon at the U. and Huntsman Cancer Hospital. Researchers elsewhere discovered some years ago that patients given high...

2008-09-03 09:00:46

FORT WASHINGTON, Pa., Sept. 3, 2008 (GLOBE NEWSWIRE) -- A new imaging system that allows physicians to examine tissue at the cellular level from inside the body may now enable them to more effectively diagnose cancer of the bile ducts, according to a new study in the September 2008 issue of the journal Clinical Gastroenterology and Hepatology. This cancer, medically known as cholangiocarcinoma, is one of the most difficult to detect and treat. "Accurate diagnosis and staging of cancer of the...

2008-08-29 03:00:20

By Howard, J Harrison Tzeng, Ching-Wei D; Smith, J Kevin; Eckhoff, Devon E; Bynon, J Steve; Wang, Thomas; Arnoletti, J Pablo; Heslin, Martin J Surgical resection of primary or metastatic tumors of the liver offers patients the best long-term survival. Liver resections may not be appropriate in patients with bilobar metastases, liver dysfunction, or severe comorbidities. Radiofrequency ablation (RFA) is a technique used to destroy unresectable hepatic tumors through thermocoagulation. We...


Latest Cholangiocarcinoma Reference Libraries

Chinese Liver Fluke, Clonorchis sinensis
2014-01-12 00:00:00

The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...

More Articles (1 articles) »
Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.